重度哮喘中超极化129Xe MRI通气缺损百分比的可重复性:评估临床试验可行性
在7例重度哮喘成人中,于两个站点24小时内进行超极化129Xe通气MRI(支气管舒张剂前后),评估全肺及逐层通气缺损百分比(VDP)的可重复性。两站点全肺VDP的组内相关系数(ICC)在支气管舒张剂前为0.90、后为0.94,逐层VDP的ICC分别为0.78和0.83;但逐层VDP在站点1显著低于站点2。
要点
- 全肺129Xe VDP在两站点间可重复性高(支气管舒张剂前ICC=0.90,后ICC=0.94)。
- 逐层129Xe VDP可重复性中等(ICC 0.78–0.83),但站点1较站点2显著偏低。
- 站点间气体分布定性差异及VDP定量差异可能与气体混合物组成或SNR不同有关。
核心结论
- 同一重度哮喘患者在两个不同站点24小时内测量的129Xe MRI VDP具有相关性。
- 站点间129Xe区域气体分布和VDP的定性与定量差异提示站点特异性变异,可能源于气体混合物组成或SNR差异。
研究设计与样本
- 研究类型为在两个站点进行的可重复性评估研究。
- 样本为7例重度哮喘成人,在24小时内于两个地理站点接受超极化129Xe通气MRI(支气管舒张剂前后)。
- 使用组内相关系数(ICC)和Bland-Altman分析评估站点间129Xe VDP的可重复性和一致性。
诊断标准与关键数值
- 全肺129Xe VDP:支气管舒张剂前ICC=0.90(p=0.005),支气管舒张剂后ICC=0.94(p<0.0001)。
- 逐层129Xe VDP:支气管舒张剂前ICC=0.78(p<0.0001),支气管舒张剂后ICC=0.83(p<0.0001)。
- 站点间129Xe剂量等效体积:站点1为101±15 mL,站点2为49±6 mL(p<0.0001)。
- 站点间SNR:站点1为40±19,站点2为23±5(p=0.02)。
- 逐层VDP站点间偏倚:支气管舒张剂前偏倚=-3%(p=0.0001),支气管舒张剂后偏倚=-2%(p=0.0003);全肺VDP偏倚:支气管舒张剂前=-3%(p>0.99),支气管舒张剂后=-2%(p=0.59)。
临床应用与阅片要点
- 全肺129Xe VDP在两站点间显示出高可重复性,可用于评估重度哮喘患者的通气功能。
- 逐层129Xe VDP可重复性中等,站点1较站点2显著偏低,阅片时需注意站点特异性变异。
- 站点间气体混合物组成(站点1为129Xe/4He,站点2为129Xe/N2)和SNR差异可能影响定量结果,解读时应考虑这些因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: 129Xe MRI has been developed to noninvasively visualize and quantify the functional consequence of airway obstruction in asthma. Its widespread application requires evidence of intersite reproducibility and agreement. Our objective was to evaluate reproducibility and agreement of 129Xe ventilation MRI measurements in severe asthmatics at two sites.
MATERIALS AND METHODS: In seven adults with severe asthma, 129Xe ventilation MRI was acquired pre- and post-bronchodilator at two geographic sites within 24-hours. 129Xe MRI signal-to-noise ratio (SNR) was calculated and ventilation abnormalities were quantified as the whole-lung and slice-by-slice ventilation defect percent (VDP). Intraclass correlation coefficients (ICC) and Bland-Altman analysis were used to determine intersite 129Xe VDP reproducibility and agreement.
RESULTS: Whole-lung and slice-by-slice 129Xe VDP measured at both sites were correlated and reproducible (pre-bronchodilator: whole-lung ICC = 0.90, p = 0.005, slice-by-slice ICC = 0.78, p < 0.0001; post-bronchodilator: whole-lung ICC = 0.94, p < 0.0001, slice-by-slice ICC = 0.83, p < 0.0001) notwithstanding intersite differences in the 129Xe-dose-equivalent-volume (101 ± 15 mL site 1, 49 ± 6 mL site 2, p < 0.0001), gas-mixture (129Xe/4He site 1; 129Xe/N2 site 2) and SNR (40 ± 19 site 1, 23 ± 5 site 2, p = 0.02). Qualitative 129Xe gas distribution differences were observed between sites and slice-by-slice 129Xe VDP, but not whole-lung 129Xe VDP, was significantly lower at site 1 (pre-bronchodilator VDP: whole-lung bias = -3%, p > 0.99, slice-by-slice bias = -3%, p = 0.0001; post-bronchodilator VDP: whole-lung bias = -2%, p = 0.59, slice-by-slice-bias = -2%, p = 0.0003).
CONCLUSION: 129Xe MRI VDP at two different sites measured within 24-hours in the same severe asthmatics were correlated. Qualitative and quantitative intersite differences in 129Xe regional gas distribution and VDP point to site-specific variability that may be due to differences in gas-mixture composition or SNR.
引用
- Svenningsen S, McIntosh M, Ouriadov A, et al. Reproducibility of Hyperpolarized 129Xe MRI Ventilation Defect Percent in Severe Asthma to Evaluate Clinical Trial Feasibility. Acad Radiol. 2020. PMID: 32417033. doi:10.1016/j.acra.2020.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。